Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Derm Vivas

Derm Vivas ·

Intralesional therapy — Viva

clinical1 min readVerification in progress
On this page
Study tools
Prompt

Write your answer

Saved on this device. No marking — you are the marker.

Q1: Definition and agents (2 min)

What is intralesional therapy? Name the main agents used in dermatology.

Expected answer: Direct injection of drug into a lesion for high local concentration. Mainstay is triamcinolone acetonide; others include 5-FU (keloid protocols), bleomycin and Candida antigen (selected warts), and less common specialised agents.

[1]

Q2: Keloid practical (3 min)

How do you inject a keloid with TAC? Concentration, endpoint, interval, escalation.

Expected answer: Confirm diagnosis/exclude infection; choose concentration for thick scar; enter scar substance; small aliquots to blanching; serial sessions; photograph. If incomplete, consider TAC+5-FU, silicone/pressure, or surgery with postoperative IL steroid in a multimodal plan. Counsel that one injection rarely cures.[2]

Q3: Alopecia areata practical (2 min)

When is IL TAC appropriate for AA? Grid concept.

Expected answer: Limited patchy AA in cooperative patients. Inject dermal grid with lower concentrations than thick keloid; serial sessions; if extensive disease, do not rely on injections alone — consider broader AA therapies.[3]

Q4: Safety (3 min)

Local and systemic risks. Face-specific caution.

Expected answer: Atrophy, telangiectasia, hypopigmentation, pain; ulceration with some non-steroid agents. Rare cumulative systemic glucocorticoid effects including Cushingoid features; rare anaphylaxis. Thin facial skin needs lower concentration and restraint.[1][2]

Q5: Pitfall (2 min)

Colleague wants to inject high-strength TAC into a soft red warm expanding plaque thought to be “scar.” Your response?

Expected answer: Stop. Warm expanding plaque may be infection or inflammatory disease — do not inject through cellulitis. Re-examine, consider antibiotics/workup, biopsy if tumour mimic. Wrong-site IL steroid worsens infection and delays diagnosis.[1]

References3ShowHide
  1. [1]Laisuan W, Wongsa C, Dchapaphapeaktak N, et al. Anaphylaxis following intralesional triamcinolone acetonide (Kenacort) injection Asia Pac Allergy, 2017.PMID 28487843
  2. [2]Jiang ZY, et al. The Safety and Efficacy of Intralesional Verapamil Versus Intralesional Triamcinolone Acetonide for Keloids and Hypertrophic Scars: A Systematic Review and Meta-analysis. Adv Skin Wound Care, 2020.PMID 32195728
  3. [3]Meah N, et al. The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata. J Am Acad Dermatol, 2020.PMID 32165196
PreviousInterstitial Lung Disease: A Review. — VivaNextJarisch-Herxheimer reaction. — Viva